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As cardiovascular diseases are the leading cause of death in the world with approximately 
17.9 million related deaths in 2016 alone, there is a great need to improve the diagnosis of 
these diseases and to prevent the following events. This problem is particularly important as 
85% of these cases could be preventable.  
Pulse wave analysis has been studied for finding markers or risk of various abnormalities 
including overall cardiovascular risk and peripheral artery disease. Arterial pulse wave analysis 
is based on measuring and evaluating arterial pulse waves that are pulsatile changes of the 
blood pressure caused by pumping of the heart. These methods could be utilized to improve the 
diagnosis of cardiovascular diseases and thus result in lowered number of events. This is based 
on the fact that these methods are non-invasive and have the potential to be widespread. 
In this thesis, arterial pulse wave analysis methods were evaluated for their impact on 
relieving this issue by evaluating the different variables and methods in question and their actual 
clinical relevance. Also, a brief overall look to commercial measurement devices was 
implemented. The study was performed by carrying out a thorough literature survey from the 
related study fields. 
Based on the literature, carotid-femoral Pulse Wave Velocity (cfPWV) was found to be the 
most prominent variable for predicting overall cardiovascular risk. Cardiovascular risk is the 
overall risk to have any cardiovascular disease and it also pertains to the risk of cardiovascular 
mortality.  
cfPWV has essential reliability and reproducibility with competent guidelines, devices and 
standardization process in place. However, the standardization still needs further efforts for 
effective and comparable widespread clinical use. The need for standardization is mainly 
caused by the fact that the methods and devices are still not uniformly used. 
Utilization of pulse wave analysis variables for improving the diagnosis of peripheral artery 
disease specifically was found to be worthwhile but further studies are still needed. One 
important aspect related to this is that until these methods are included into peripheral artery 
disease guidelines, there is no relevant clinical benefit available from them. 
As a whole, pulse wave analysis methods are intensively studied as a tool for diagnosis, but 
the varieties in measurement and on analysis methods at clinical circumstances as well as lack 
of validation continue to be major obstacles that prevent these methods from breaking through. 
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LIST OF ABBREVIATIONS AND SYMBOLS 
AAA Abdominal aortic aneurysm 
CAD Coronary artery disease 
CVD Cardiovascular disease 
PAD Peripheral artery disease 
 
ABI Ankle-to-brachial (pressure) index 
AIx Augmentation index 
ASI Arterial stiffness index 
cfPWV Carotid-femoral pulse wave velocity 
cPP Central pulse pressure 
cSBP Central systolic blood pressure 
DC Diastolic rate constant 
PRT   Pulse rise time 
PWA Pulse wave analysis 
PWV Pulse wave velocity 
SC Systolic rate constant 
SEVR Subendocardial viability ratio 
 
AHA   American Heart Association 
WHO World Health Organization 
 
BSN   Body sensor network 
ECG Electrocardiogram 
EMFI Electromechanical film 
IPG Impedance plethysmography 
IPPG Imaging photoplethysmography 
MRI Magnetic resonance imaging 
PPG Photoplethysmography 
 
CO Cardiac output 
DBP Diastolic blood pressure 
DPTI Diastolic pressure–time index 
HR Heart rate 
LV Left ventricular 
MAP Mean arterial pressure 
SBP Systolic blood pressure 
SPTI Systolic pressure–time index 
SVR Systemic vascular resistance 
 
C compliance 
D distensibility 
𝜀 strain 
P pressure 
ρ blood density 
R resistance 
s distance 
T time 
V volume 
Z impedance 
1 
 
1. INTRODUCTION 
Cardiovascular diseases (CVD) are the leading cause of death in the world. In 2016, 
approximately 17.9 million deaths were caused by CVD [1]. The incidents of CVD will 
only increase as a result of the rising prevalence of risk factors in low-risk countries [2]. 
But in fact, a great part of these fatalities and expenses could be avoided. World Health 
Organization (WHO) has estimated that 75% of premature CVD cases are preventable 
[3]. In addition to mortality, the health care expenses of CVDs are causing significant 
economic pressure on countries. 
This study investigates whether arterial pulse wave analysis methods are able to relieve 
the vast amount of cardiovascular mortality by better prediction and diagnosing. Focus 
will be on the actual pulse wave analysis variables such as pulse wave velocity (PWV) 
and augmentation index (AIx) and on the measurement methods such as applanation 
tonometry and oscillometric measuring. Also, the actual clinical value of these variables 
and measurements methods for predicting overall CVD risk or for diagnosing peripheral 
artery disease (PAD) will be discussed. This study does not cover the implementation of 
pulse wave analysis methods on children. 
Firstly, the related vascular diseases coronary artery disease (CAD), PAD and aortic 
aneurysms, will be introduced as these are conditions, which affect on the observed 
pulse waves. Then, the risk factors, such as high blood pressure and arterial stiffness 
causing CVDs will be discussed as these are conditions that are important part of pre-
dicting CVDs. The third chapter will address the basics of pulse waves, the variables that 
can be extracted from them and how they are measured. In the fourth chapter, the clinical 
value of pulse wave analysis for predicting overall cardiovascular risk is discussed. Sub-
sequently, the possibilities for diagnosing PAD are considered. Lastly, in the fifth chapter, 
the most important observations and conclusions are combined together. 
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2. VASCULAR DISEASES 
Vascular diseases are a sub-group of CVDs. Vascular diseases are specifically a condi-
tion of the circulatory system, where normal function of a blood vessel or of several blood 
vessels is deteriorated with a varying impact.  
For this study, the focus will be on CAD, PAD and aneurysms amongst all cardiovascular 
diseases, since the changes in pulse waves caused by these diseases are best detected 
by arterial pulse wave analysis (PWA) methods. Hypertension and arterial stiffness will 
also be discussed as these are risk factors for cardiovascular diseases. 
2.1 Coronary artery disease (CAD) 
Coronary artery disease refers to a narrowing of coronary arteries. These essential ar-
teries supply the heart with oxygen and are thus crucial for the functioning of the heart. 
In the case of CAD, where an artery has substantially narrowed or completely blocked, 
heart attack, heart failure or rhythm disorders of the heart can take place. Therefore, it is 
important to diagnose CAD in an early state to be able to treat it and prevent complica-
tions. [4] 
Atherosclerosis, a hardening of arteries, is the cause of CAD. It is caused by minor in-
flammations that originate in the arterial walls and by substances such as cells and fats 
traveling in these arteries that stick to these sites and form plaques as seen in Figure 1. 
[4] 
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Figure 1. Illustration of the plaque buildup in CAD and consequences [5]. 
The risk factors for CAD are both affectable and unaffectable. The factors that can be 
affected at least partially are high blood pressure, high cholesterol levels, obesity, lack 
of exercising, unhealthy diet, stress, smoking, and diabetes. The factors that one cannot 
affect are sex, ethnicity and family history. Also, the risk of having coronary artery dis-
ease increases with aging. [4] 
2.2 Peripheral artery disease (PAD) 
Peripheral artery disease is a disorder where peripheral arteries have decreased perfu-
sion caused by a buildup of plaques, as seen in Figure 2 [6]. It is a subtype of athero-
sclerosis. The peripheral arteries in question supply limbs and pelvis with oxygen-rich 
blood.  [6] 
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Figure 2. Illustration of a normal artery (A) and an artery of a PAD patient (B). In 
Subfigure 2.B there is a deposit of plague in an artery and normal perfusion is dis-
turbed [7]. 
PAD can cause ischemia or insufficient blood supply for the tissue. If the arteries of the 
lower limbs have PAD lesions, this can cause intermittent claudication, rest pain or may 
even lead to an amputation of a limb due to necrosis [6, 8]. More importantly, J.W. Olin 
& B.A. Sealove have pointed out in [9] that PAD often progresses as undiagnosed and 
can result in poor quality of life or depression. It also increases the risk of having a heart 
attack or stroke. 
Risk factors of PAD include diabetes, smoking, obesity, hypertension, high cholesterol 
levels, heart disease, stroke, aging and having a family history of PAD. Smoking in-
creases the risk of having PAD by fourfold. [6] 
2.3 Aneurysm 
Aneurysm is a condition where an artery has an enlargement and it can rupture [10]. This 
type of abnormal balloon-like swelling, as illustrated in Figure 3, occurs as a result of a 
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weakened artery wall. Aortic aneurysms are either thoracic or abdominal. Abdominal 
aortic aneurysms (AAA) are the most common type of aneurysms. [11] 
 
Figure 3. Illustration of the difference between normal aorta (A) and aorta with an 
aneurysm (B) & (C) [12]. 
Commonly, when a segment of abdominal aorta exceeds 3.0 cm in diameter, it is con-
sidered as an aortic aneurysm. However, most of AAAs are asymptomatic and minority 
detected by imaging of stomach that is done solely for treating another illness. This is 
critical as any AAA exceeding 5 cm in diameter is prone to rupture and in case of rupture, 
over 50% of the incidents are fatal due to patient not reaching emergency room in time. 
[13] 
AAAs occur as the media of an artery degenerates whilst the lumen of the artery enlarges 
in a progressive manner. Risk factors for aneurysm include age over 65, smoking, being 
a Caucasian male, chronic obstructive pulmonary disease, CAD, prior aneurysm repair 
and high blood pressure. [13] 
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2.4 Risk factors 
Risk factors for cardiovascular diseases are fairly similar and the two most significant 
ones for predicting CVDs are high blood pressure and arterial stiffness. Firstly, high blood 
pressure will be discussed and then arterial stiffness. 
2.4.1 Hypertension (high blood pressure) 
Hypertension is an important risk factor for cardiovascular diseases [14, pp. 1, 15]. It is 
a serious condition that has been attributed to 54% of strokes and 45% of CADs incidents 
that occur worldwide [16]. It is also linked with the development of aneurysms and PAD 
[17, 18]. 
Blood pressure is stated as a pair of systolic and diastolic value. For example, 130/80 
mmHg informs that systolic value is 130 mmHg and diastolic 80 mmHg. However, the 
actual definition of high blood pressure is controversial. Commonly as a general guide, 
blood pressure is regarded as high if the systolic value exceeds 140 mmHg and/or the 
diastolic value exceeds 90 mmHg. [19] 
The prevalence of hypertension increases with aging. It is mostly caused by lifestyle 
choices but there are also genetic causes. The affecting lifestyle choices are smoking, 
obesity, excessive salt usage, too low activity, use of painkillers, use of hormones, use 
of alcohol and stress are common causes of hypertension. [20] 
2.4.2 Arterial stiffness 
Arterial stiffness describes the diminished ability of an artery to correspond with pressure 
changes by expanding or contracting [21]. It varies in different regiments of the body. For 
example, a healthy subject has large arteries that are more elastic than the smaller ar-
teries of the subject.  
Stiffening of the arteries is one of the key factors affecting pulse pressure, left ventricular 
(LV) load and coronary perfusion pressure [22]. Most importantly, arterial stiffness is 
thought as one of the most critical risk factors for the incidence of a cardiovascular event 
[23]. It has been also suggested that it can precede and play a role in developing hyper-
tension [24]. 
Physical variables of arterial stiffness are compliance (C) and distensibility (D). Compli-
ance represents the change in the diameter of an artery depending on pressure. It can 
be presented in the following way 
𝐶 =
∆𝑉
∆𝑃
        (1) 
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where ∆𝑉 is the change in volume and ∆𝑃 is the change in pressure. In a healthy artery, 
there is a significant change in volume with even a small pressure change. On the other 
hand, in a stiffened artery only a small change in volume will occur even with a significant 
pressure change. [21] 
Distensibility describes the value of arterial compliance with respect to the initial diameter 
of an artery [21]. It can be presented in the following way: 
𝐷 =
∆𝑉
∆𝑃
∙ 𝑉       (2) 
where ∆𝑉 is the change in volume, ∆𝑃 is the change in pressure and 𝑉 is the initial 
volume. [21] 
With increased arterial stiffness, the propagation velocity of a pressure pulse wave in-
creases within the arterial tree. This is called pulse wave velocity (PWV), which pertains 
to arterial distensibility and in the simplest model it is presented as 
PWV =
1
√𝜌∙𝐷
= √
𝐸𝑖𝑛𝑐ℎ
2𝑟𝜌
       (3) 
where ρ is the blood density, D is distensibility, 𝐸𝑖𝑛𝑐 is the elastic modulus of the artery, 
h is the wall thickness and r is the radius of the artery. [14, pp. 20, 21]  
Due to ageing, arteries get stiffer and dilate. These changes are most visible in the aorta 
and its close-by branches. There are also changes in the structural layers of arteries The 
layers of the arteries are outer adventitia, tunica media and inner tunic intima. As the 
artery stiffens, individual elastin lamellae get thinner in the media and the tunic intima 
thickens.  
The traditional cardiovascular risk factors can contribute to developing arterial stiffness. 
Notably, also chronic kidney disease can have a negative impact. [23] 
Large arteries with atherosclerosis i.e. narrowing of the artery due to plaque build-up, for 
example in CAD and PAD, also show increased stiffness. Furthermore, hypertension can 
cause arterial stiffening as a result of increased pressure faced. [21] The genetic factors 
also play a role in arterial stiffness development. [24] 
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3. PULSE WAVES 
This chapter will go over physiology of pulse waves, what variables are extracted from 
them and how pulse waves are measured with different methods. Lastly, the commercial 
pulse wave analysis devices are reviewed. 
3.1 Pulse pressure waveform 
Pulse wave is a recording presenting the pulsatile pressure changes of the blood pres-
sure caused by pumping of the heart. It is composed of propagating forward waves and 
of reflecting backward waves from peripheral arteries. These waves travel along the ar-
terial tree. The reflected backward waves are caused by arterial bifurcations (branching), 
atherosclerotic plagues and terminal arterioles. A demonstration of an aortic pulse wave-
form is provided in Figure 4. [14, pp. 9, 45-53] 
 
Figure 4. Illustration of a pulse wave. The dark blue line is the forward propagating 
wave caused by systole. The red line is the combination of reflected waves and the 
light blue is a combination of these two, a pulse wave. Adapted from [25]. 
In a young person with healthy arteries, the reflected wave returns in diastole. But with 
a person who has stiffened arteries, the reflected wave increases in speed and magni-
tude. This causes the reflected wave to return already in systole as seen in Figure 5.A. 
This results in increased pulse pressure, in increased LV afterload and in a decrease in 
P (mmHg) 
t (ms) 
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the myocardial perfusion pressure, as seen in Figure 5.B. These are significant changes 
as the circulation of the heart functions primarily during diastole and thus relies to a de-
gree on the normal propagation of the reflected waves. [25] 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Pulse waveform of a person with stiffened arteries (A). Changes in the 
pulse waveform highlighted, which were caused by the earlier arrival of the reflected 
wave (B). Adapted from [25]. 
However, it is important to recognize that the pulse pressure waveform differs even both 
from person to person and even in the same person in different arteries. The waveform 
5.A 
5.B 
t (ms) 
t (ms) 
 
P (mmHg) 
P (mmHg) 
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depends on the left ventricular ejection, the viscoelastic properties of an artery, on the 
viscosity of the blood, as well as on the wave reflection and dispersion. [26] 
PWA is needed as Mean Arterial Pressure (MAP) does not clarify the differences in dif-
fering blood pressures, since MAP only is determined as multiplication of three parame-
ters: Heart Rate (HR), Cardiac Output (CO) and Systemic Vascular Resistance (SVR). 
An example below, in Figure 6, describes two subjects: (a) with normal blood pressure 
values and (b) with distinctive hypertension. While the other subject has hypertension, 
they both still have the same MAP. [14, pp. 3-7] 
Figure 6. An example of the insufficiency of the MAP. Subject (a) with regular blood 
pressure values and (b) with distinctive hypertension values. Still, both have the same 
MAP. [14, pp. 6, 24] 
Similarly, two subjects who have same systolic blood pressure (SBP) and diastolic blood 
pressure (DBP), can have substantially different pulse waveforms. These both examples 
express that critical information is possibly left undiscovered with traditional variables. 
Important variables such as central Pulse Pressure (cPP), AIx and Subendocardial Via-
bility Radio (SEVR) can be derived from a pulse waveform and have been widely re-
searched for the analysis of the state of cardiovascular health. 
However, these parameters are details of the central arterial system and they can only 
be acquired invasively or by extracting them from a peripheral measurement with a help 
of a transfer function [14, pp. 114, 27]. It is important to note that the application is not 
always focused on central circulatory system information and thus does not always re-
quire a transfer function. 
The use of a transfer function causes error as it is a generalized function used to convert 
peripheral arterial information into central arterial information of the aorta. This type of 
function assumes that every subject has similar arterial properties, and this is not true. 
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The resulting error could be solved by use of an individually defined transfer function but 
defining such for every subject is too laborious. These transfer functions have been 
shown to have sufficient accuracy for generating the arterial properties of an aorta but 
still they are considered as an additional error factor. [27] 
3.2 Pulse wave analysis (PWA) 
Pulse wave is analysed by examining the waveform or the PWV or with a combination 
of both. [14, pp. 17; 69] The relevant variables for pulse wave analysis are currently: 
PWV, AIx, Arterial Stiffness Index (ASI), cPP, SEVR, Systolic rate Constant (SC) and 
Diastolic rate Constant (DC). 
As arterial stiffness is an important independent key risk factor for developing a CVD and 
a possible event, most studies focus on analysing variables related to arterial stiffness.  
Such arterial stiffness related variables are PWV, AIx and ASI. 
PWV (propagation of the wave along the arterial tree) is the current gold standard for 
predicting risk of cardiovascular disease. This is the most studied way of evaluating ar-
terial stiffness [28]. PWV can be presented in the following way 
PWV =  
𝑠
∆𝑇
        (4) 
where 𝑠 is the distance between two different measuring sites of pulse waves and ∆𝑇 is 
the time difference of the pulse wave arrivals at these two sites. The reproducibility and 
reliability of PWV have been confirmed by a vast amount of scientific literature [29-31]. 
[14, pp. 20]  
There are extended reference values presented by many different studies for most of the 
continents excluding Africa. The lack of universal standardization and reference values 
with consensus is still a major problem for PWV. [32, 33] In related expert consensus 
document [34], a PWV value of 10 m/s was proposed in 2012 as a threshold value but 
use of such fixed thresholds is not advisable as all factors are not taken into considera-
tion, for example, a transient increase in MAP can lead to deceived conclusions [34]. 
AIx is a variable presenting the increase in blood pressure caused by the early arrival of 
a pulse wave. AIx is measured in percentages and can be presented in the following way 
 𝐴𝐼𝑥 =  
𝑆𝐵𝑃−𝑃𝑖
𝑐𝑃𝑃
× 100%      (5) 
where 𝑆𝐵𝑃 is the central Systolic Blood Pressure, 𝑃𝑖 is the inflection point it is the blood 
pressure value in the point where backward wave starts to superimpose with the forward 
wave and 𝑐𝑃𝑃 is the central Pulse Pressure i.e. the change in systolic and diastolic blood 
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pressure, as seen in Figure 7. The inflection point is not always clear and may require 
analysis of the fourth derivate. Augmented pressure (AP), which can be seen in Figure 
7, describes the same phenomenon, but in a unit of pressure instead of percentages. 
[14, pp. 70] 
AIx relates both to arterial stiffness and pulse wave velocity. There are a significant 
amount of studies showing it to effectively predict cardiovascular events. However, it is 
not a generally accepted variable for evaluating arterial stiffness as there lies controversy 
on its credibility [14, pp. 73-80, 35, 36]. The largest issue is that heart rate affects AIx 
and thus it is not an independent measure of arterial stiffness [37]. 
Furthermore, AIx has limitations as a measure of wave reflection [38]. The mathematical 
equation of the variable has a clear issue meaning that earlier arrival of reflected waves 
may not be identified correspondingly. Basically, a rise in AP won’t necessarily mean 
that there is an increase in AIx, unless cPP is stable. This is problematic as a rise in AP 
is commonly accompanied by an increase in cPP. [36] 
Lastly, a transfer function is commonly used to derive AIx and this creates error. When 
compared with PWV this means that AIx includes an additional error factor. [14, pp. 28, 
27]  
Arterial stiffness index (ASI) is a variable originating from 24-hour ambulatory blood pres-
sure monitoring. It has been proposed as a variable for evaluating cardiovascular risk in 
an easy manner. It can be presented in the following way: 
𝐴𝑆𝐼 =  
ln
𝑆𝐵𝑃
𝐷𝐵𝑃
𝜀
        (6) 
where SBP is the systolic blood pressure, DBP is the diastolic blood pressure (Figure 7) 
and 𝜀 is the occurred arterial strain [39]. Where there are studies that show it to be linked 
with cardiovascular indices, it is in fact heavily affected by vascular resistance and deci-
sively by heart rate in addition to arterial stiffness [40, 41]. This limits the use of it as a 
variable to evaluate arterial stiffness. Due to this it is also not recommended for the eval-
uation of cardiovascular risk. [42] 
cPP as derived from pulse wave analysis, has as well been introduced as an independ-
ent variable for predicting CVDs. It can be presented in the following way 
𝑐𝑃𝑃 =  𝑐𝑆𝐵𝑃 − 𝐷𝐵𝑃       (7) 
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where cSBP is central systolic blood pressure and DBP diastolic blood pressure as seen 
in Figure 7. [14, pp. 70]  
Figure 7. Illustration of pulse waveform and related variables: cSBP, cPP, DBP, 
and AP [14, pp. 70]. 
There have been studies that have found a relationship between cPP and cardiovascular 
mortality but overall the predictive impact is marginally better than traditional blood pres-
sure measurements and is not a recommend variable. This is the consensus even if it 
could provide a bit better risk stratification. [40, 43] Also, use of transfer function is often 
needed to obtain cPP and this again causes error in the results. 
SEVR is a variable derived from the waveform of a pulse. It is determinated by means of 
dicrotic notch, which is a small and brief increase in blood pressure that occurs after 
aortic valve closes, it can be seen in Figure 8 [44]. SEVR can be presented in the follow-
ing way 
 𝑆𝐸𝑉𝑅 =  
𝐷𝑃𝑇𝐼
𝑆𝑃𝑇𝐼
        (8) 
where DPTI is the diastolic pressure-time index, it withholds the area after the dicrotic 
notch, and SPTI is the systolic pressure-time index, the area before the dicrotic notch. 
This can be perceived in Figure 8, where the dicrotic notch divides these two areas. [14, 
pp. 71]  
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Figure 8. Illustration of pulse waveform and SPTI, DPTI, and MAP variables [14, 
pp. 71]. The dicrotic notch separates SPTI and DPTI [44]. 
Even though it is actually a variable that describes whether the heart is getting enough 
oxygen to function, there has been continuous research regarding its potential to be a 
CVD predictor. Correlations between SEVR and CVD cases have been observed and a 
critical value of 0.5 has been proposed for this variable [45]. SEVR below 0.5 is consid-
ered as an indicator of restricted subendocardial blood flow and oxygen supply. [14, pp. 
92] 
Most recently, H-M Cheng et al. in their study [46] studied variables SC and DC with a 
reservoir model. The reservoir model takes into consideration the systolic charging and 
diastolic discharging of the arterial system. 
In the model, SC describes the filling of the reservoir. It can be presented in the following 
way 
SC =  
1
𝑍0𝐶
        (9) 
where 𝑍0 is the characteristic impedance of the root of the aorta and C is total arterial 
compliance [47]. 
On the other hand, DC describes the draining of the reservoir. It can be presented in the 
following way 
DC =  
1
𝑅𝐶
        (10) 
Dicrotic notch 
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where R is systemic arterial resistance and C is the total arterial compliance [47]. This 
connection of SC and DC with pulse wave can be seen in Figure 9 [46]. 
Figure 9. Illustration of pulse waveform and relating variables, SC and DC [46]. 
Study concluded that by studying the pulse waveforms of two cohorts that SC and DC 
were independent and consistent predictors of cardiovascular mortality. [46] 
Limitations of the study were that a transfer function was used for deriving carotid pres-
sure waveform and the study did have a disagreement with an earlier study [48]. Overall, 
more research is needed to confirm these findings and to resolve the disagreements. 
Also, for any actual clinical impact, the reference values for SC and DC must be deter-
mined and the measurement must be standardized. [46] Lastly, these variables should 
be only considered relevant if and when they are included into pulse wave analysis re-
lated guidelines. 
Besides the aforementioned analysis methods, new pulse wave analysis variables are 
proposed continuously. However, they are often at least initially based on insufficient 
data. Such two proposed indexes are arterial velocity pulse index and arterial pressure 
volume index as stated in [49] by R. Sasaki-Nakashmia et al. Despite the fact that the 
indexes were stated promising independent factors these were actually compared with 
unreliable brachial-ankle pulse wave velocity (baPWV).  
baPWV is unreliable and unsuitable measurement for cardiovascular risk evaluation as 
it is a peripheral measurement and thus does not consider arterial properties of an aorta 
[14, pp. 28]. For example, with subjects that have aortic diseases baPWV produces in-
accurate measurements and it may underestimate the arterial stiffness of a subject with 
hypertension [50, 51]. There is a better measurement available that considers these ar-
terial properties of the aorta and it is the aortic pulse wave velocity (cfPWV) [14, pp. 28].  
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3.3 Measurement of pulse waves 
Pulse waves can be measured both invasively and non-invasively [14, pp. 107]. Due to 
the nature of invasive methods, non-invasive methods are preferred.  
Present non-invasive methods are applanation tonometry, photoplethysmography 
(PPG), impedance plethysmography (IPG), electromechanical transducers, Magnetic 
Resonance Imaging (MRI) and oscillometric measurement. Body sensor network (BSN) 
systems have also been implemented [52].  
As PWV is widely accepted as the gold standard method, most measuring methods focus 
on solely obtaining it, but naturally, the actual pulse waveform is acquired as well. 
3.3.1 Applanation tonometry 
In applanation tonometry, a probe that contains at least one force sensor is used for 
detecting the arrival of pulse waves at different sites [53]. In practice, one presses the 
arterial area against underlying bone for the recording of a pulse wave, as can be seen 
in Figure 10. For acquiring PWV, the pulse waves are recorded either simultaneously at 
two sites or separately with the help of an additional electrocardiograph. [14, pp. 20-23] 
Figure 10. Illustration of a probe being utilized in applanation tonometry for recording 
of an arterial pulse wave [14, pp. 110]. 
The most common recording site combination is carotid-femoral, it is illustrated in Figure 
11. This specific measurement and produced cfPWV are the current gold standard with 
the disadvantage of estimated distance instead of an exact one. The key advantage of 
this method is that the viscoelastic properties of an aorta are taken into consideration as 
the proximal sensor is measuring PWV along the aorta. [14, pp. 28] 
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Other combinations such as carotid-radial or carotid-brachial have as well been studied 
but these measurement methods are not suitable for clinical purposes. [14, pp. 36]  
Figure 11. Measuring of cfPWV by capturing carotid and femoral pressure wave-
forms simultaneously [14, pp. 21]. 
In the first method, proximal and peripheral pressure waveforms are recorded simulta-
neously with transducers. With the proximal and peripheral pulse waveform, the time 
delay can be calculated. Then the cfPWV can be calculated by dividing the distance of 
transducers with the time delay. [14, pp. 20-21] 
Alternatively, cfPWV can be acquired by measuring the pulse waves at different sites in 
separate times with only one transducer. In this method, electrocardiogram (ECG) is also 
recorded and time delay is calculated by examining the time delays of both pulse waves 
to the R waves of QRS complex. Again, cfPWV is formed by dividing the distance of 
transducers with the time delay. [14, pp. 21-23] 
Overall, applanation tonometry is considered as easy, fast and as the most reliable 
method. However, it is also an expensive one and needs an experienced operator. With 
applanation tonometry, both pulse waveform and pulse wave velocity are acquired.  [14, 
pp. 21; 28] 
3.3.2 Photoplethysmography (PPG) 
With photoplethysmography, the recorded signal is dependent on the peripheral blood 
volume and measurement is done by utilizing a light source and a light detector. It can 
be used for measuring blood pressure, blood oxygen saturation (use of at least two dif-
ferent wavelengths required) and the arterial condition of a patient. However, PPG for 
blood pressure measurement is not common due to limitations. The potential of PPG for 
an accurate pulse wave measuring has been pointed out by several studies [54, 55]. [56] 
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It has caught the interest of researchers due to it being an easy, simple and inexpensive 
measurement method. Basically, a through propagating cardiovascular pulse wave is 
detected via a probe that has a light source and a detector, as seen in Figure 12 where 
PPG finger clip sensor is used as an example. PPG reflects the blood volume changes 
occurring in an artery. The artery is either between heart and fingertip, if measured from 
a fingertip or between heart and toe if measured from a toe. [57] 
Figure 12. An example of a PPG finger clip sensor, which is using infrared light. 
Adapted from [58]. 
Another proposed method to record PWV is with a collar and a bracelet by the Vicorder® 
device. A collar with a photoplethysmographic sensor is placed on the neck of a patient 
and a bracelet is placed on the root of the patient’s thigh. However, measurement of 
distance and both the validity and relation to other measurements methods need further 
investigating. [14, pp. 128] 
Additionally, video-based or imaging photoplethysmography (IPPG) has also been stud-
ied as a method for acquiring data of pulse waves. However, due to the lack of studies 
on obtaining information on the of central pulse waves, if at all possible, this method 
seems to be irrelevant. Furthermore, it is still in its infancy as low sample frequency and 
the feared inaccuracy caused by motion artifacts are a problem. [59, 60] 
Overall, the traditional PPG is an easy and inexpensive measuring alternative. However, 
one must consider that pulse waves undergo an amplification phenomenon in the arterial 
tree and thus recording from a peripheral site cannot give the most accurate information 
of the central properties, as a transfer function is employed. Applications in obese sub-
jects where other methods may fall short due to fatty deposits preventing signal acquisi-
tion could be a potential more frequent indication. [61] 
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3.3.3 Impedance plethysmography (IPG) 
In impedance plethysmography, an alternating current with frequency typically between 
20 kHz and 100 kHz is applied through electrodes to estimate inner arterial cross-sec-
tional area of the arteries between the measurement sites. This method is based on the 
fact that blood has higher conductivity than other tissues.  [62] 
IPG is not recommended for pulse wave analysis as it is not clearly stated as such in the 
American Heart Association (AHA) scientific statement [33] or in the European expert 
consensus document [63]. Its accuracy might as well be hindered by the fact that it can-
not separate an artery and vein from each other due to it being extracorporeal. Also, 
even the slightest change in the electrode positioning can cause prominent changes in 
the amplitude of the bioimpedance. Thus, the calibration must be very precise. [62] 
However, if the measurements can be performed in a way that veins are not taken into 
account by accident, IPG could be a potential measuring method that also considers the 
viscoelastic properties of the aorta. There are several relevant studies published recently 
[64-66]. But, without a doubt extensive amount of studies will still be needed, also with 
cohorts, to decide the true usability of IPG.   
3.3.4 Electromechanical transducers 
Electromechanical transducers have been widely studied for acquiring data of pulse 
waves [67-69]. Measurement devices based on these sensors can be energy-efficient 
and inexpensive alternatives to capture pulse waves [70]. Also, their quality of being thin 
and flexible is a clear advantage. Suitable sensors are either acceleration, pressure or 
displacement sensors. [71] Significant limitation of these transducers is that they will not 
give information about the diastolic blood pressure as they are only sensitive to dynamic 
loading.  
Often, a piezoelectric film is employed, and it is placed on top of an artery. As an artery 
vibrates the film is deformed proportionally to pressure. [71] 
Another choice is an electromechanical film (EMFi), which is a permanently charged 
electret material. As external dynamic force is being applied to the EMFi, a displacement 
charge is caused to the surface electrodes due to a change in internal charge distribution. 
This all originates from changes in air void thicknesses, which separate the multiple pol-
ypropylene layers that form the film. [52] 
For piezoelectric films, the sensor positioning, and noise vulnerability are key corner-
stones to account for in order to make this method widely usable. Currently, this type of 
measuring system can only be used at a resting state. As any motion of a body artifact 
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movement greater than that of a pulse wave will be superimposed. [71] Also, for a force 
sensor it is key to use a fitting static force to flatten the artery but not to occlude it [52]. 
Limiting factor for both piezoelectric films and EMFis is the usual peripheral measure-
ment, which does not give the most accurate information of the aortic pulse wave. How-
ever, a product on a market called The Complior System® is a promising example of this 
method as it uses two piezoelectric sensors that are in fact placed on carotid and femoral 
arteries [14, pp. 127-128]. 
3.3.5 Oscillometric methods 
Oscillometric cuffs and bracelets have been employed for obtaining pulse waves. Oscil-
lometric devices are mostly supposed to register pulsatile pressure changes in a brachial 
artery [61]. These devices are an easy and affordable method with a possibility of wide-
spread use. 
Oscillometric devices on the market include the ARCSolver system, the Arteriograph 
System, BPLab the VaSera System and Tel-O-GRAPH. The physiological hypotheses 
of these devices are often questioned [14, pp. 126; 129]. However, they perform accept-
ably in studies and Tel-O-GRAPH performed actually with excellent accuracy [72-74].  
ARCSolver and Arteriograph have shown acceptable accuracy when compared with an 
intra-aortic catheter when analyzed as assayed with the Bland-Altman method [72]. Also, 
BPLab and the Arteriograph similarly performed with acceptable accuracy when com-
pared with applanation tonometry [73-76].  
Most importantly, Tel-O-GRAPH performed in an excellent manner in a recent study 
done in 2017, when compared with applanation tonometry. So, it seems that even when 
peripheral measurements are used, excellent correlation can be achieved. [77] 
Overall, peripheral oscillometric measurement seems a fickle way for pulse wave velocity 
extraction due to the aortic stiffness and overall central pulse waveform being signifi-
cantly different than that of radial, brachial or axillary regions [14, pp. 57]. However, these 
results suggest that oscillometric measurement could be a viable measurement method 
with high reproducibility and reliability. Naturally, more studies with a greater cohort are 
needed to confirm these findings. 
3.3.6 Magnetic resonance imaging (MRI) 
Magnetic resonance imaging is without a doubt the most high-end measuring method 
[78]. With MRI one can extract accurately aortic vascular parameters such as compli-
ance, stiffness, ASI, and PWV. This is due to the possibility of assessing pretty much 
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any artery, getting an accurate PWV value from it and getting exact distance measure-
ment. [32] 
MRI proves to be especially useful for obese subjects. As with these subjects, the dis-
tance measurement is more prone to be a false one. [79] So, the direct imaging of tho-
racic and abdominal aorta is a clear advantage of this method. The limitations causing 
MRI not to be a widespread measuring method are mainly the costs and additionally lack 
of commercial software available that can be used for computing PWV. [80] 
3.3.7 Devices on the market 
There are devices on the market with different measuring approaches. The diagnostic 
quality of the devices varies deeply and some of the devices are rather just easy to use 
with a possibility of no plausible scientific background [14, pp. 129-130]. Most commonly, 
the measurement is based on applanation tonometry, but oscillometric methods are com-
mon as well. However, with oscillometric methods, there is still a lack of independent 
validation studies and of comparative data. [81] Relevant pulse wave measurement de-
vices are presented in Table 1. 
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Instrument Manufacturer Method cfPWV cPP Reference 
Arterio-
graph® TensioMed Ltd. Oscillometric   (x) [14, pp. 129, 83] 
BPLab® 
OOO Petr Tele-
gin Oscillometric x   [81] 
CardioMon® Medifina Oscillometric   (x) [14, pp. 128-129] 
Complior® Alarm Medical 
Piezoelectric 
sensors x x 
[14, pp. 127-128, 
35, 81] 
Mobil-O-
Graph® IEM Oscillometric   (x) 
[14, pp.  126, 80, 
83] 
Omron HEM-
9000AI® 
Omron 
Healthcare co. 
Ltd. Tonometry   (x) [14, pp. 127] 
PulsePen 
ETT® DiaTence srl Tonometry x x [14, pp. 126 ,81] 
PulsePen ET® DiaTence srl 
Tonometry + 
ECG x x [14, pp. 126, 81] 
SphygmoCor® 
AtCor Medical 
Pty. Ltd. 
Tonometry + 
ECG x x [14, pp. 127, 81] 
VaSera® 
Fukuda Denshi 
Co. Ltd. Oscillometric x  [14, pp. 128, 35, 82] 
Vicorder® 
Skidmore Medi-
cal Ltd. 
Photo- 
plethysmo-
graphy (x) (x) [14, pp. 128] 
     x validated device; (x) further studies are needed for validation 
Arteriograph, BPLab, CardioMon, Mobil-O-Graph and VaSera devices use the oscillome-
tric measuring. Arteriograph, CardioMon and Mobil-O-Graph can measure cPP. BPLab 
and VaSera are capable of measuring PWV [35, 82]. Arteriograph, CardioMon and Mobil-
O-Graph have been considered to need further studies [83]. [14, pp. 126-129, 81] 
The devices based on tonometry are Omron HEM-9000AI, PulsePen ETT, PulsePen ET 
and SphygmoCor. Tonometry is considered as the best measuring method and the de-
vices can measure both cfPWV and cPP with the exception of Omron HEM-9000AI. [14, 
pp. 127] Omron HEM-9000AI was in fact considered to require further studies for true 
validation. [84] 
Commercially available devices using other measuring methods are Complior and Vi-
corder as stated by P. Salvi in [14, pp. 126]. Complior utilizes two sensitive piezoelectric 
sensors for obtaining the carotid and femoral pulse waveforms simultaneously [35, 81].  
Vicorder is a photoplethysmographic method using a collar and a bracelet. The collar 
with photoplethysmographic sensors is placed on a patient’s neck to acquire carotid 
Table 1.   Devices on the market measuring cfPWV and/or cPP [14, pp. 
125-130, 81].  
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pulse wave and the bracelet is placed on the root of the patient’s thigh. The actual 
method, distance measurement and relationship with other devices still require further 
studies to be verified as credible and reproducible [85, 86]. [14, pp. 128]  
The greatest aspect to understand with these devices is that the devices are based on 
different techniques and produce different results. This highlights the need for reference 
values and standards that consider the different circumstances related to the PWV meas-
urement. These circumstances such as ethnicity and the varying device used will affect 
how the results should be interpreted.  
24 
 
4. CLINICAL VALUE OF PULSE WAVE ANALYSIS 
In this chapter, focus will first be on the value of pulse wave analysis for detecting overall 
raised risk of a cardiovascular disease. Then, possibilities for diagnosing peripheral ar-
tery disease will be discussed.  
Even though AAA patients have shown to have deviant AIx values, there are no promi-
nent results currently for utilizing pulse wave analysis methods for the diagnosis of AAA 
[87]. Thus, pulse wave analysis methods for diagnosis of AAA will not be discussed.  
4.1 Overall cardiovascular risk 
Aortic stiffness is widely understood as an independent predictor of cardiovascular inci-
dence [88]. Its evaluation with carotid-femoral pulse wave velocity, the gold standard 
method, improves the prediction of cardiovascular risk. [31] The nomination as gold 
standard was stated both in AHA scientific statement [35] and in European expert con-
sensus document [63]. Furthermore, cfPWV meets most of the criteria that are expected 
from a surrogate endpoint [89]. 
On the other contrary, carotid-radial, carotid-brachial, femoro-tibial and brachial-ankle 
site combinations for PWV measurement are not considered suitable for general cardio-
vascular risk assessment [14, pp. 36-38]. 
Aortic pulse wave velocity is in theory ready for clinical use in Europe as there are widely 
recognized reference values published [90] that are based on European cohort. Intrinsi-
cally this requires use of a validated PWV measurement device and following of related 
guidelines in AHA scientific statement [35] and in European expert consensus document 
[63]. 
However, it should also be taken into consideration that the study of the reference values 
[90] was limited by 1) No information of PWV evolution over time, 2) Consensus needs 
to be reached whether to use these values as cut-off values, 3) Different techniques were 
used, and this was also compensated for.  
For the other continents, the individual reference value studies should be verified and 
combined into continental specific reference value in order to produce similar guidelines. 
This is especially important so that different ethnic backgrounds are taken into consider-
ation. 
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To accomplish widespread active clinical use of pulse wave velocity as a predictor of 
cardiovascular risk, aortic pulse wave velocity measurement must be standardized. 
There is a great need for studies and measurements to be more comparable and unam-
biguously interpretable. The key matters to standardize are PWV measurement device, 
distance measurement, MAP incorporation and measuring circumstances [32]. [29] 
The measurement should be done with validated PWV measurement device and further-
more this validation process of a device should be standardized. With a validated device, 
one gets comparable results and has reference values to support the research. The val-
idation of a device should be independent and comparable with the validation processes 
other devices have undergone. Ultimately, it would be ideal to have interchangeable de-
vices. However, the devices must at least have fitting reference values that take under 
consideration continental differences. [29, 91] 
In the carotid-femoral PWV measurement, the distance measurement can be conducted 
by two different approaches. First approach is to measure from suprasternal notch to the 
femoral site (b) minus the suprasternal notch-to-carotid distance (a), these path lengths 
are illustrated in Figure 13. The second approach is direct measurement from carotid site 
to femoral site and the direct measure should be multiplied by 0.8, this path length is 
illustrated in Figure 13 as well. [14, pp. 23-25, 29] The recommended equipment for 
distance measurement is calipers [35]. 
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Figure 13. Illustration of the two distance measurement approaches to acquire dis-
tance for PWV determination. Vector (a) is the suprasternal notch-to-carotid distance, 
vector (b) is the suprasternal notch-to-femoral distance and vector (c) is the carotid-to-
femoral distance. Vector (b) – (a) is the first approach and vector (c) on its own is the 
direct distance measurement. [92] 
A single threshold value should not be used for interpreting the PWV value as impacting 
factors are not taken to consideration such as age and the association with MAP. The 
measurement sites and measuring process should also be reported in the studies. As 
distance has a great impact on the resulting PWV and falsely measured one can cause 
significant error. [29] 
The MAP values should be measured and incorporated to the research papers, because 
interventions lowering MAP, will also lower PWV. Basically, this means that a decrease 
in PWV is not always a result of an improved arterial stiffness condition. In order to inter-
pret that arterial stiffness condition has been improved there must be a decrease in PWV 
to a degree that is not justified by decrease of MAP alone. [29] 
The measurement of PWV should be done while the patient is in fasted state. Duplicate 
PWV measurements should be conducted, after a 10-minute rest period and the patient 
should be laying down in supine position. Lastly, the operator should be familiar with the 
measuring device, is trained to perform measurements and accomplishes reproducible 
results. [29, 34] 
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Other potential variables to assess cardiovascular risk are SEVR and a combination of 
SC and DC. However, the local PWV measurement is always more accurate than PWV 
or another variable acquired as a result of PWA and a transfer function. SEVR currently 
has only a critical value of 0.5, below this subendocardial vascularization is deficient [14, 
pp. 92]. DC and SC still need further studies, including longitudinal ones, to determine 
their true accuracy, reproducibility, and appropriate reference values. 
Oscillometric methods, EMFi, and piezoelectric sensors, and PPG are the inexpensive 
methods to make accurate PWV measurement broadly available. Success in such inex-
pensive devices would greatly increase the clinical value of pulse wave analysis. 
4.2 Peripheral artery disease 
Non-invasive diagnosis of PAD is commonly done with affordable ankle-brachial index 
(ABI). However, it is severely limited in case of calcification to a degree where an artery 
cannot be flattened and thus no reliable measurement can be acquired. [93] The accu-
racy of ABI also has variability and specificity, thus PWA-derived variables such as AIx, 
PWV, and pulse rise time (PRT) have been proposed as alternative methods to improve 
the accuracy [94, 95]. Out of the PWV-variables, AIx and PWV pertain to pulse waves of 
the aorta and PRT pertains to the peripheral pulse waves. So far, these PWA-derived 
variables are not an essential part of PAD guidelines. 
AIx derived from applanation tonometry is independently associated with PAD and has 
clinical potential [96]. It has been shown that PAD is characterized with an increase in 
AIx with respect to controls. PWV is also increased with PAD patients. [97-98] However, 
with these variables, further studies are needed to validate them and acquire reference 
values. Also, separation of PAD from other abnormalities causing increased PWV or AIx 
might as well prove to be an issue. The advantage of AIx is that only a single measure-
ment site is needed.  
Another approach is cPP/PWV index that has been proposed as a risk factor for severe 
PAD. This has its basis on that PWV lowers with people with PAD [99], which is not in 
consensus with the previous PWV and AIx studies [96-98]. The cohort in the study was 
larger than in previous related studies. The decrease of PWV could be thought to result 
from increased flow resistance, where the increased flow resistance is caused by the 
occlusion of an artery. 
In any case, the relationship of PWV and PAD should be confirmed. With confirmation 
and further research, a decrease in PWV and an increase in cPP could be an efficient 
way to predict increased risk of PAD [99]. 
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PRT derived by means of PPG and measured from a toe is another potential approach. 
PRT is regarded as the time between a local minimum before pulse wave peak and the 
peak of the pulse wave.  This PRT is measured and evaluated from a lower limb. It was 
an effective PAD marker in a recent study, but studies with larger sample size and dif-
ferent ethnic cohorts are needed to validate the method and the critical value. The ad-
vantages of PRT-based method are the inexpensive, convenient and easy measure-
ment. [96] 
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5. CONCLUSION 
PWA methods are intended for predicting cardiovascular diseases primarily by evaluat-
ing arterial stiffness. Optimized and standardized measurement with the right variable 
can be affordable widespread way of predicting CVDs with significant clinical value. 
Notable pulse wave analysis variables are PWV, AIx, ASI, cPP, SEVR, and a combina-
tion of SC and DC. Out of these the most viable and recommended one is cfPWV. This 
is mainly based on the fact that PWA variables commonly depend on use of a general-
ized transfer equation. 
The most common measuring methods currently for pulse wave analysis are applanation 
tonometry and oscillometric measurement. Even though tonometry with carotid-femoral 
site combination is the recommended method with the best accuracy and reproducibility, 
the results are operator dependent. The essential aspect of applanation tonometry with 
carotid-femoral site combination is that viscoelastic properties of an aorta are taken into 
consideration. 
On the other hand, oscillometric methods can also have acceptable accuracy and suffi-
cient reproducibility. The oscillometric measurement could be an easy and affordable 
method capable of widespread use. However, oscillometric devices need independent 
studies to confirm their validity. A main drawback of oscillometric measurement is that it 
is a peripheral measurement, which means that use of a transfer function is required in 
order to acquire the central pulse waveform. 
Additionally, although electromechanical transducer and PPG measuring methods are 
still unpopular commercially, they possess a vast amount of potential to be affordable 
and easy measuring method that could become widespread, with extended measuring 
possibilities such as BSN applications. Whereas PPG can have extensive use with obese 
subjects, use of transfer equation can be a pitfall for these methods. 
Currently, cfPWV is clinically relevant but the widespread impact needs standardization. 
The key aspects to be standardized are the usage of validated PWV measurement de-
vice with adequate reference values, distance measurement and incorporation of it to 
the related document, incorporation of MAP to the related document, using recom-
mended measuring conditions and sufficient operator training. 
PWA has utilization prospect in the diagnosis of PAD by enhancing the diagnosis made 
with ABI. However, they are not an established part of PAD guidelines and require further 
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research. The researched variables are AIx, PWV, cPP/PWV, and PRT. The conflicting 
findings on whether PWV increases or decreases with PAD need to be addressed prior 
to any clinical usage of PWV related variables for PAD diagnosing. 
To conclude, pulse wave analysis methods are intensively studied as a tool for diagnosis, 
but the varieties in measurement and on analysis methods at clinical circumstances as 
well as lack of validation continue to be major obstacles that prevent these methods from 
breaking through. Eventually, success of standardization will decide the success and 
impact of these methods. 
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